EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue Sarcoma

EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue Sarcoma

Purpose. This study investigates the efficacy and toxicity of daily oral etoposide in chemotherapy for non-heavily pretreated advanced and metastatic soft tissue sarcoma (STS).

Bibliographic Details
Main Authors: H. Jan Keizer, Derek Crowther, Ole Steen Nielsen, Allan T. Van Oosterom, Javier Hornedo Muguiro, Christine Van Pottelberghe, Renier Somers, Thomas Tursz
Format: Article
Language:English
Published: Hindawi Limited 1997-01-01
Series:Sarcoma
Online Access:http://dx.doi.org/10.1080/13577149778371
id doaj-0e73ffa9b99246b68b4408694ee6a1e8
record_format Article
spelling doaj-0e73ffa9b99246b68b4408694ee6a1e82020-11-24T22:08:12ZengHindawi LimitedSarcoma1357-714X1369-16431997-01-01129910110.1080/13577149778371EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue SarcomaH. Jan Keizer0Derek Crowther1Ole Steen Nielsen2Allan T. Van Oosterom3Javier Hornedo Muguiro4Christine Van Pottelberghe5Renier Somers6Thomas Tursz7Leiden University Hospital, The NetherlandsUniversity of Manchester, UKAarhus University Hospital, DenmarkUniversity Hospital of Antwerp, BelgiumMadrid Hospital Universitario, SpainEORTC Data Center, BelgiumNetherlands Cancer Institute, The NetherlandsInstitut Gustave-Roussy, FrancePurpose. This study investigates the efficacy and toxicity of daily oral etoposide in chemotherapy for non-heavily pretreated advanced and metastatic soft tissue sarcoma (STS).http://dx.doi.org/10.1080/13577149778371
collection DOAJ
language English
format Article
sources DOAJ
author H. Jan Keizer
Derek Crowther
Ole Steen Nielsen
Allan T. Van Oosterom
Javier Hornedo Muguiro
Christine Van Pottelberghe
Renier Somers
Thomas Tursz
spellingShingle H. Jan Keizer
Derek Crowther
Ole Steen Nielsen
Allan T. Van Oosterom
Javier Hornedo Muguiro
Christine Van Pottelberghe
Renier Somers
Thomas Tursz
EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue Sarcoma
Sarcoma
author_facet H. Jan Keizer
Derek Crowther
Ole Steen Nielsen
Allan T. Van Oosterom
Javier Hornedo Muguiro
Christine Van Pottelberghe
Renier Somers
Thomas Tursz
author_sort H. Jan Keizer
title EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue Sarcoma
title_short EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue Sarcoma
title_full EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue Sarcoma
title_fullStr EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue Sarcoma
title_full_unstemmed EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue Sarcoma
title_sort eortc group phase ii study of oral etoposide for pretreated soft tissue sarcoma
publisher Hindawi Limited
series Sarcoma
issn 1357-714X
1369-1643
publishDate 1997-01-01
description Purpose. This study investigates the efficacy and toxicity of daily oral etoposide in chemotherapy for non-heavily pretreated advanced and metastatic soft tissue sarcoma (STS).
url http://dx.doi.org/10.1080/13577149778371
work_keys_str_mv AT hjankeizer eortcgroupphaseiistudyoforaletoposideforpretreatedsofttissuesarcoma
AT derekcrowther eortcgroupphaseiistudyoforaletoposideforpretreatedsofttissuesarcoma
AT olesteennielsen eortcgroupphaseiistudyoforaletoposideforpretreatedsofttissuesarcoma
AT allantvanoosterom eortcgroupphaseiistudyoforaletoposideforpretreatedsofttissuesarcoma
AT javierhornedomuguiro eortcgroupphaseiistudyoforaletoposideforpretreatedsofttissuesarcoma
AT christinevanpottelberghe eortcgroupphaseiistudyoforaletoposideforpretreatedsofttissuesarcoma
AT reniersomers eortcgroupphaseiistudyoforaletoposideforpretreatedsofttissuesarcoma
AT thomastursz eortcgroupphaseiistudyoforaletoposideforpretreatedsofttissuesarcoma
_version_ 1725817233907646464

Similar Items